Experimental studies of the pathogenesis of infections due to Pseudomonas aeruginosa: description of a burned mouse model
- PMID: 805812
- DOI: 10.1093/infdis/131.6.688
Experimental studies of the pathogenesis of infections due to Pseudomonas aeruginosa: description of a burned mouse model
Abstract
An experimental burned mouse model is described that is clinically relevant to burn wound sepsis caused by Pseudomonas aeruginosa. Mice subjected to a nonlethal burn by flame were challenged with P. aeruginosa. The LD50 after subcutaneous injection in the skin of the burn up to 24 hr after the burn was smaller than 10 organisms vs. 10-6 organisms in normal animals. By three days after the burn, the value returned to and exceeded that of normal animals. This dramatic change in the LD50 after the burn was not seen when mice were challenged with other organisms. Challenge with P. aeruginosa by different routes immediately after burning showed less dramatic decreases in the LD50. Enumeration of infecting organisms in the skin of the burn and in major organs suggests the possibility of a toxic event.
Similar articles
-
Immunization with 3-oxododecanoyl-L-homoserine lactone-r-PcrV conjugate enhances survival of mice against lethal burn infections caused by Pseudomonas aeruginosa.Bosn J Basic Med Sci. 2015 May 25;15(2):15-24. doi: 10.17305/bjbms.2015.292. Bosn J Basic Med Sci. 2015. PMID: 26042508 Free PMC article.
-
Effect of transforming growth factor-beta neutralization on survival and bacterial clearance in a murine model of Pseudomonas aeruginosa burn wound infection.J Burn Care Res. 2006 Sep-Oct;27(5):682-7. doi: 10.1097/01.BCR.0000238083.95170.2A. J Burn Care Res. 2006. PMID: 16998401
-
A Nonlethal Murine Flame Burn Model Leads to a Transient Reduction in Host Defenses and Enhanced Susceptibility to Lethal Pseudomonas aeruginosa Infection.Infect Immun. 2021 Sep 16;89(10):e0009121. doi: 10.1128/IAI.00091-21. Epub 2021 Jun 21. Infect Immun. 2021. PMID: 34152806 Free PMC article.
-
[Experimental vaccinal prophylaxis of Pseudomonas aeruginosa burn sepsis].Zh Mikrobiol Epidemiol Immunobiol. 1989 Jul;(7):59-62. Zh Mikrobiol Epidemiol Immunobiol. 1989. PMID: 2510430 Russian.
-
Systemic inflammatory responses and multiple organ dysfunction syndrome following skin burn wound and Pseudomonas aeruginosa infection in mice.Shock. 2013 Aug;40(2):152-9. doi: 10.1097/SHK.0b013e31829aef41. Shock. 2013. PMID: 23707977
Cited by
-
Safety and immunogenicity of a Pseudomonas aeruginosa O-polysaccharide toxin A conjugate vaccine in humans.J Clin Invest. 1987 Jul;80(1):51-6. doi: 10.1172/JCI113062. J Clin Invest. 1987. PMID: 3110215 Free PMC article.
-
Use of monoclonal antibodies to protein F of Pseudomonas aeruginosa as opsonins for phagocytosis by macrophages.Infect Immun. 1987 Oct;55(10):2531-3. doi: 10.1128/iai.55.10.2531-2533.1987. Infect Immun. 1987. PMID: 3115901 Free PMC article.
-
X-linked immunodeficient mice as a model for testing the protective efficacy of monoclonal antibodies against Pseudomonas aeruginosa.Infect Immun. 1988 May;56(5):1209-14. doi: 10.1128/iai.56.5.1209-1214.1988. Infect Immun. 1988. PMID: 3128480 Free PMC article.
-
Role of peptide hydrophobicity in the mechanism of action of alpha-helical antimicrobial peptides.Antimicrob Agents Chemother. 2007 Apr;51(4):1398-406. doi: 10.1128/AAC.00925-06. Epub 2006 Dec 11. Antimicrob Agents Chemother. 2007. PMID: 17158938 Free PMC article.
-
Protection against experimental Pseudomonas aeruginosa infection in mice by active immunization with exotoxin A toxoids.Infect Immun. 1981 May;32(2):681-9. doi: 10.1128/iai.32.2.681-689.1981. Infect Immun. 1981. PMID: 6788700 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources